Is Capecitabine Safe in Patients with Gastrointestinal Cancer and Dihydropyrimidine Dehydrogenase Deficiency?-Reference-Cited by-同舟云学术

Is Capecitabine Safe in Patients with Gastrointestinal Cancer and Dihydropyrimidine Dehydrogenase Deficiency?

Published:2006-01 Issue:5 Volume:5 Page:359-362
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Saif M. Wasif,Diasio Robert

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference24 articles.

1. Semi-automated radioassay for determination of dihydropyrimidine dehydrogenase (DPD) activity. Screening cancer patients for DPD deficiency, a condition associated with 5-fluorouracil toxicity;Johnson;J Chromatogr B Biomed Sci Appl,1997

2. Preferential activation of capecitabine in tumor following oral administration in colorectal cancer patients;Schüller;Cancer Chemother Pharmacol,2000

3. Plasma levels of 5-fluorouracil after oral and intravenous administration in cancer patients;Finch;Br J Clin Pharmacol,1979

4. Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-flourouracil in colorectal cancer;Nita;Hepatogastroenterology,1998

5. The role of pharmacogenetics and pharmacogenomics in cancer chemotherapy with 5-fluorouracil;Diasio;Pharmacology,2000

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Capecitabine-associated gastrointestinal ulceration, haemorrhage, and obstruction: a pharmacovigilance analysis based on the FAERS;Frontiers in Pharmacology;2024-06-14

2. Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans;Journal of the National Medical Association;2023-04

3. Issues and limitations of available biomarkers for fluoropyrimidine-based chemotherapy toxicity, a narrative review of the literature;ESMO Open;2021-06

4. Capecitabine-Induced Terminal Ileitis: Case Report and Literature Review;Cureus;2021-04-21

5. Capecitabine Induced Hand-Foot Syndrome: A Systematic Review of Case Reports;Clinical and Experimental Health Sciences;2019-06-30